What is Mulberry Leaf used for?

Mulberry Leaf (Morus alba) carries a Grade C rating — limited evidence. Strongest recorded design is a meta analysis, drawn from 3 recorded studies, 3 in people. No disagreement is recorded across them. Recorded activity centres on metabolic regulation, AMPK signaling and glucose metabolism support, which describes mechanism rather than demonstrated benefit. Noted cautions include hypoglycemia risk and pregnancy/breastfeeding without clinician guidance.

Herb Profile

Mulberry Leaf

Morus alba

Mulberry Leaf (Morus alba) carries a Grade C rating — limited evidence.

Last reviewed: June 6, 2026•3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution — May potentiate glucose lowering drugs; GI effects possible; pregnancy safety uncertain. Details

Evidence: Limited Evidence
Typical onset: Varies by prep
Safety rating: Moderate caution
Best for: Metabolic
Avoid / review if: Hypoglycemia Risk, Pregnancy/Breastfeeding Without Clinician Guidance, May Potentiate Antidiabetic Drugs And Other Alpha Glucosidase Inhibitors

Generated profile category visual

At a glance

From this profile's structured data

Evidence: Grade C
Safety: May potentiate glucose-lowering drugs; GI effects possible; pregnancy safety uncertain.
Profile context: metabolic

Next stepsWhere to go next — guides & comparisons

If you want to browse more herbs → All herbs

Safety

Safety & Cautions

May potentiate glucose lowering drugs; GI effects possible; pregnancy safety uncertain.

Elevated caution

Caution level: Elevated. One caution category applies — read it before use.

Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.

Detailed safety fields

Pregnancy, breastfeeding, and contraindications

Hypoglycemia Risk
Pregnancy/Breastfeeding Without Clinician Guidance
May Potentiate Antidiabetic Drugs And Other Alpha Glucosidase Inhibitors
Monitor Glucose.

Safety classifications

Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

May potentiate glucose lowering drugs; GI effects possible; pregnancy safety uncertain.

Safety labels

Pregnancy/Breastfeeding Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Moderate Caution

110 flagged pairings

Blood-sugar lowering

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Blood-sugar loweringCertainty: Theoretical

Data provenance recorded for 110 of 110 pairings in this mechanism group.

+98 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Metabolic Regulation · AMPK Signaling · Glucose Metabolism Support

Research maturity: Emerging research — Long Term Human Evidence May Be Limited.

Safety boundary: Safety note available — May potentiate glucose lowering drugs; GI effects possible; pregnancy safety uncertain.

This profile cites 3 human studies.

Study design details

Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match: Meta-analysis
Risk of Bias: Low
Consistency: Consistent

Strongest recorded design is a meta-analysis, drawn from 3 recorded studies, 3 in people. No disagreement is recorded across them.

How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong: Multiple RCTs, consistent direction, adequate effect size
Moderate: Some RCTs or consistent observational data in humans
Preliminary / Mixed: Animal or in-vitro only, or conflicting human data
Traditional / Theoretical: Traditional use only; no controlled human trials

Clinical Study Summaries (5)3 human evidence sources · 2 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 5 of 5 studies.

What the evidence actually shows

This table contains 5 structured sources, including 3 human evidence sources; 2 are human trials.

Study	Design	N	Dose	Duration	Population	Outcome	Result & magnitude	Source
A 2023 systematic review/meta-analysis of 12 trials (615 participants) reported reductions in fasting glucose, HbA1c, and fasting insulin. Heterogeneity and preparation differences still matter, so this supports a metabolic signal rather than a treatment claim. Background	Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.	—	—	—	—	—	A 2023 systematic review/meta-analysis of 12 trials (615 participants) reported reductions in fasting glucose, HbA1c, and fasting insulin. Heterogeneity and preparation differences still matter, so this supports a metabolic signal rather than a treatment claim.	PubMed →
Understanding the Impact of Different Doses of Reducose(®) Mulberry Leaf Extract on Blood Glucose and Insulin Responses after Eating a Complex Meal: Results from a Double-Blind, Randomised, Crossover Trial Thondre PS et al. · Nutrients · 2024 Background	Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.	—	—	—	—	—	—	PubMed →
A 12-week randomized study of a DNJ-standardized mulberry-leaf product reported dose-related glycemic effects and gastrointestinal adverse events, supporting both constituent-standardization and GI-tolerability tagging. Background	Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.	—	—	—	—	—	A 12-week randomized study of a DNJ-standardized mulberry-leaf product reported dose-related glycemic effects and gastrointestinal adverse events, supporting both constituent-standardization and GI-tolerability tagging.	PubMed →
Mulberry leaves ameliorate diabetes via regulating metabolic profiling and AGEs/RAGE and p38 MAPK/NF-κB pathway Li JS et al. · J Ethnopharmacol · 2022 Background	Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.	—	—	—	—	—	—	PubMed →
Mulberry leaf improves type 2 diabetes in mice via gut microbiota-SCFAs-GPRs axis and AMPK signaling pathway Zhang Y et al. · Phytomedicine · 2025 Background	Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.	—	—	—	—	—	—	PubMed →

Dosing & Timing

No standardized dose: Preparation specific; use standardized product label for Leaf tea and require source backed dosage review before therapeutic claims.

How Mulberry Leaf works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Mulberry Leaf Works

CompoundTarget / ReceptorMechanismEffect / Outcome

Mechanisms & biological pathways (preclinical)

Metabolic Regulation
AMPK Signaling
Glucose Metabolism Support
Lipid Metabolism Support

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Open the full activity atlasCompare effects, evidence, and safety

Guides that use Mulberry Leaf

Condition guides

Fat loss

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Mulberry Leaf

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Continue comparing

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Suggest an ingredient, comparison, or study →

Free safety checklist

Get the Mulberry Leaf research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

← Back to herbs library Safety checker →